The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women


DOI: https://dx.doi.org/10.18565/pharmateca.2022.4.26-32

S.S. Apetov, V.V. Apetova

Endocrine Health Center, Chelyabinsk, Russia
The incidence of type 2 diabetes mellitus (DM2) is constantly increasing worldwide, becoming a significant health problem due to the higher risk of cardiovascular complications associated with this disease. A better understanding of the DM2 pathophysiology in postmenopausal women may change prevention strategies and improve treatment outcomes. The role of menopausal hormone therapy in the prevention of DM2 is not fully understood, mainly due to the lack of sufficient results from randomized clinical trials; the available data, however, indicate a significant reduction in the risk of newly diagnosed DM2 in patients receiving this therapy.

About the Autors


Corresponding author: Sergey S. Apetov, Cand. Sci. (Med.), Endocrinologist, Obstetrician-Gynecologist, Endocrine Health Center, Chelyabinsk, Russia; apetov@rambler.ru, https://orcid.org/0000-0001-8053-8561


Similar Articles


Бионика Медиа